Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group

Leukemia

Volumn 20, Issue 9, 2006, Pages 1539-1541

  Mehta, P A ^a   Davies, S M ^a   Kumar, A ^b   Devidas, M ^c   Lee, S ^a   Zamzow, T ^a   Elliott, J ^a   Villanueva, J ^a   Pullen, J ^d   Zewge, Y ^a   Filipovich, A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Florida ^*  (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; PERFORIN; VALINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; B CELL LEUKEMIA; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 33747618010     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404299     Document Type: Article

References (19)

1. Young JD, Cohn ZA, Podack ER. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: Structural, immunological, and functional similarities. Science 1986; 233: 184-190.
2. Podack ER, Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 1983; 302: 442-445.
3. Podack ER, Young JD, Cohn ZA. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci USA 1985; 82: 8629-8633.
4. Dennert G, Podack ER. Cytolysis by H-2-specific T killer cells: Assembly of tubular complexes on target membranes. J Exp Med 1983; 157: 1483-1495.
5. Masson D, Tschopp J. Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J Biol Chem 1985; 260: 9069-9072.
6. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2: 735-747.
7. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathad PA et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957-1959.
8. Feldmann J, Le Deist F, Ouachee-Chardin M, Certain S, Alexander S, Quartier P et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol 2002; 117: 965-972.
9. Molleran Lee S, Villanueva J, Sumegi J, Zhang K, Kogawa K, Davis J et al. Characterization of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet 2004; 41: 137-144.
10. Zur Stadt U, Beutel K, Weber B, Kabisch H, Schneppenheim R, Janka G. A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood 2004; 104: 1909-1910.
11. Busiello R, Galgani M, De Fusco C, Poggi V, Adriani M, Racioppi L et al. Role of A91V mutation in perforin gene in hemophagocytic lymphohistiocytosis. Blood 2004; 104: 1910.
12. Busiello R, Adriani M, Locatelli F, Galgani M, Fimiani G, Clementi R et al. Atypical features of familial hemophagocytic lymphohistiocytosis. Blood 2004; 103: 4610-4612.
13. Trambas C, Gallo F, Pende D, Marcenaro S, Moretta L, De Fusco C et al. A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood 2005; 106: 932-937.
14. Risma K, Frayer R, Filipovich A, Sumegi J. Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest 2006; 116: 182-192.
15. Santoro A, Cannella S, Trizzino A, Lo Nigro L, Corsello G, Arico M. A single amino acid change A91V in perforin: A novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Hematologica 2005; 90: 697-698.
16. Clementi R, Emmi L, Maccario R. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 2002; 100: 2266-2267.
17. Smyth M, Thia K, Street S, MacGregor D, Godfrey DI, Trapani JA. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 2000; 192: 755-760.
18. Clementi R, Dagna L, Dianzani U, Dupre L, Dianzani I, Ponzoni M et al. Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma. N Engl J Med 2004; 351: 1419-1424.
19. Clementi R, Locatelli F, Duprè L, Garaventa A, Emmi L, Bregni M et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood 2005; 105: 4424-4428.